EMD Serono
One Technology Place
Rockland
MA
02370
United States
Tel: 800-283-8088
Website: https://www.emdserono.com/us-en
234 articles with EMD Serono
-
Bioject Medical Technologies Inc. Announces New Supply Agreement with Merck Serono
10/11/2007
-
ZymoGenetics, Inc. (Jobs) and Merck Serono Receive FDA Special Protocol Assessment for Atacicept Pivotal Study in Lupus Nephritis
10/4/2007
-
Immunicon Corporation Announces Laboratory Services and Assay Development Agreements with Merck Serono
8/29/2007
-
Gene Logic Inc. Establishes Agreement with Merck Serono to Discover New Development Paths for Multiple Clinical-Stage Drug Candidates
8/23/2007
-
BioMarin Pharmaceutical Inc.'s (Jobs) Kuvan Receives Priority Review Status from FDA
7/26/2007
-
Squeeze Out of Merck Serono Shares Successfully Completed
7/6/2007
-
BioMarin Pharmaceutical Inc. Submits New Drug Application for U.S. Marketing Authorization of Kuvan for Phenylketonuria (PKU)
5/24/2007
-
Merck Serono to Voluntarily Delist and Deregister its Bearer Shares and American Depositary Shares (Evidenced by American Depositary Receipts)
4/5/2007
-
Merck Serono Preliminary Q4/FY 06 Results - March 1
2/28/2007
-
Aurigene Discovery Technologies Limited And Merck Serono Enter A Discovery Collaboration To Identify Therapeutics For Autoimmune Disorders
2/2/2007
-
The Day In Review: Alfacell Receives Orphan Drug Status For Onconase
1/30/2007
-
Merck Serono Launches easypod(R), First Electronic Growth Hormone Injection Device
1/30/2007
-
Merck Serono Has Initiated The ONWARD Study To Evaluate Oral Cladribine As Add-on Treatment For Multiple Sclerosis
1/24/2007
-
Merck Serono Completes Patient Enrollment In CLARITY Phase III Pivotal Clinical Trial Of Oral Cladribine
1/16/2007